Charles Schwab’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $183K | Buy |
25,398
+12,712
| +100% | +$91.7K | ﹤0.01% | 3381 |
|
|
2025
Q1 | $105K | Sell |
12,686
-1,600
| -11% | -$13.2K | ﹤0.01% | 3337 |
|
|
2024
Q4 | $569K | Buy |
14,286
+2,306
| +19% | +$91.9K | ﹤0.01% | 3107 |
|
|
2024
Q3 | $104K | Buy |
11,980
+10,725
| +855% | +$92.9K | ﹤0.01% | 3376 |
|
|
2024
Q2 | $11K | Hold |
1,255
| – | – | ﹤0.01% | 3610 |
|
|
2024
Q1 | $30.8K | Hold |
1,255
| – | – | ﹤0.01% | 3410 |
|
|
2023
Q4 | $20.8K | Hold |
1,255
| – | – | ﹤0.01% | 3477 |
|
|
2023
Q3 | $23.4K | Hold |
1,255
| – | – | ﹤0.01% | 3496 |
|
|
2023
Q2 | $30.5K | Buy |
+1,255
| New | +$30.5K | ﹤0.01% | 3502 |
|
|
2022
Q3 | – | Sell |
-2,959
| Closed | -$90K | – | 3509 |
|
|
2022
Q2 | $90K | Sell |
2,959
-1,994
| -40% | -$60.6K | ﹤0.01% | 3297 |
|
|
2022
Q1 | $267K | Sell |
4,953
-610
| -11% | -$32.9K | ﹤0.01% | 3245 |
|
|
2021
Q4 | $1.65M | Buy |
5,563
+150
| +3% | +$44.5K | ﹤0.01% | 2760 |
|
|
2021
Q3 | $2.1M | Buy |
5,413
+1,851
| +52% | +$718K | ﹤0.01% | 2694 |
|
|
2021
Q2 | $1.82M | Buy |
3,562
+698
| +24% | +$356K | ﹤0.01% | 2748 |
|
|
2021
Q1 | $1.63M | Buy |
2,864
+283
| +11% | +$161K | ﹤0.01% | 2708 |
|
|
2020
Q4 | $1.78M | Buy |
+2,581
| New | +$1.78M | ﹤0.01% | 2620 |
|